Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 144

1.

Relationships between immunophenotype, Ki-67 index, microvascular density, Ep-CAM/P-cadherin, and MMP-2 expression in early-stage invasive ductal breast cancer.

Niemiec JA, Adamczyk A, Małecki K, Majchrzyk K, Ryś J.

Appl Immunohistochem Mol Morphol. 2012 Dec;20(6):550-60. doi: 10.1097/PAI.0b013e31824f21af.

PMID:
22531681
2.

Tumor grade and matrix metalloproteinase 2 expression in stromal fibroblasts help to stratify the high-risk group of patients with early breast cancer identified on the basis of st Gallen recommendations.

Niemiec J, Adamczyk A, Małecki K, Ambicka A, Ryś J.

Clin Breast Cancer. 2013 Apr;13(2):119-28. doi: 10.1016/j.clbc.2012.12.005. Epub 2013 Jan 31.

PMID:
23375518
3.

Prognostic significance of Ep-CAM AND Her-2/neu overexpression in invasive breast cancer.

Spizzo G, Obrist P, Ensinger C, Theurl I, Dünser M, Ramoni A, Gunsilius E, Eibl G, Mikuz G, Gastl G.

Int J Cancer. 2002 Apr 20;98(6):883-8.

4.

Triple-negative, basal marker-expressing, and high-grade breast carcinomas are characterized by high lymphatic vessel density and the expression of podoplanin in stromal fibroblasts.

Niemiec JA, Adamczyk A, Ambicka A, Mucha-Małecka A, M Wysocki W, Ryś J.

Appl Immunohistochem Mol Morphol. 2014 Jan;22(1):10-6. doi: 10.1097/PAI.0b013e318286030d.

PMID:
23455186
6.

Tumor-derived matrix metalloproteinase-13 (MMP-13) correlates with poor prognoses of invasive breast cancer.

Zhang B, Cao X, Liu Y, Cao W, Zhang F, Zhang S, Li H, Ning L, Fu L, Niu Y, Niu R, Sun B, Hao X.

BMC Cancer. 2008 Mar 28;8:83. doi: 10.1186/1471-2407-8-83.

7.

Expression and prognostic significance of metalloproteases and their inhibitors in luminal A and basal-like phenotypes of breast carcinoma.

González LO, Corte MD, Junquera S, González-Fernández R, del Casar JM, García C, Andicoechea A, Vázquez J, Pérez-Fernández R, Vizoso FJ.

Hum Pathol. 2009 Sep;40(9):1224-33. doi: 10.1016/j.humpath.2008.12.022. Epub 2009 May 12.

PMID:
19439346
8.

Expression of matrix metalloproteinases and their inhibitors in different immunohistochemical-based molecular subtypes of breast cancer.

Kim GE, Lee JS, Choi YD, Lee KH, Lee JH, Nam JH, Choi C, Kim SS, Park MH, Yoon JH, Kweon SS.

BMC Cancer. 2014 Dec 16;14:959. doi: 10.1186/1471-2407-14-959.

10.

Clinicopathologic features of breast carcinomas classified by biomarkers and correlation with microvessel density and VEGF expression: a study from Thailand.

Chuangsuwanich T, Pongpruttipan T, O-Charoenrat P, Komoltri C, Watcharahirun S, Sa-Nguanraksa D.

Asian Pac J Cancer Prev. 2014;15(3):1187-92.

11.

Expression of Ep-CAM in cervical squamous epithelia correlates with an increased proliferation and the disappearance of markers for terminal differentiation.

Litvinov SV, van Driel W, van Rhijn CM, Bakker HA, van Krieken H, Fleuren GJ, Warnaar SO.

Am J Pathol. 1996 Mar;148(3):865-75.

12.

P-cadherin and cytokeratin 5: useful adjunct markers to distinguish basal-like ductal carcinomas in situ.

Paredes J, Lopes N, Milanezi F, Schmitt FC.

Virchows Arch. 2007 Jan;450(1):73-80. Epub 2006 Nov 23.

PMID:
17123107
13.

Expression of cell adhesion molecules and prognosis in breast cancer.

Saadatmand S, de Kruijf EM, Sajet A, Dekker-Ensink NG, van Nes JG, Putter H, Smit VT, van de Velde CJ, Liefers GJ, Kuppen PJ.

Br J Surg. 2013 Jan;100(2):252-60. doi: 10.1002/bjs.8980. Epub 2012 Nov 22.

PMID:
23175431
14.

Loss of membranous Ep-CAM in budding colorectal carcinoma cells.

Gosens MJ, van Kempen LC, van de Velde CJ, van Krieken JH, Nagtegaal ID.

Mod Pathol. 2007 Feb;20(2):221-32.

15.

Prognostic effect of epithelial cell adhesion molecule overexpression in untreated node-negative breast cancer.

Schmidt M, Hasenclever D, Schaeffer M, Boehm D, Cotarelo C, Steiner E, Lebrecht A, Siggelkow W, Weikel W, Schiffer-Petry I, Gebhard S, Pilch H, Gehrmann M, Lehr HA, Koelbl H, Hengstler JG, Schuler M.

Clin Cancer Res. 2008 Sep 15;14(18):5849-55. doi: 10.1158/1078-0432.CCR-08-0669.

16.

[Relationship between epithelial-mesenchymal transition and basal cell-like phenotype in breast cancer].

Wu WX, Zhang YP, Wen XW, Lu N, Tang ZY, Zhang Y, Wang Z, Wang W, Yang HJ.

Zhonghua Bing Li Xue Za Zhi. 2009 Aug;38(8):519-23. Chinese.

PMID:
20021961
17.

Epithelial cell adhesion molecule (Ep-CAM) modulates cell-cell interactions mediated by classic cadherins.

Litvinov SV, Balzar M, Winter MJ, Bakker HA, Briaire-de Bruijn IH, Prins F, Fleuren GJ, Warnaar SO.

J Cell Biol. 1997 Dec 1;139(5):1337-48.

18.

p63, cytokeratin 5, and P-cadherin: three molecular markers to distinguish basal phenotype in breast carcinomas.

Matos I, Dufloth R, Alvarenga M, Zeferino LC, Schmitt F.

Virchows Arch. 2005 Oct;447(4):688-94. Epub 2005 Oct 19.

PMID:
16012853
19.

Correlation of E-cadherin expression and routine immunohistochemistry panel in breast invasive ductal carcinoma.

Mohammadizadeh F, Ghasemibasir H, Rajabi P, Naimi A, Eftekhari A, Mesbah A.

Cancer Biomark. 2009;5(1):1-8. doi: 10.3233/CBM-2009-0551.

PMID:
19242056
20.

Histological grade as an alternative to the Ki67 labeling index is only available for luminal-type breast cancers.

Hayashi S, Kitada M, Sato K, Matsuda Y, Ishibashi K, Oikawa K, Miyokawa N, Hirata S.

Breast Cancer. 2014 Jan;21(1):47-51. doi: 10.1007/s12282-012-0353-2. Epub 2012 Mar 31.

PMID:
22467403

Supplemental Content

Support Center